Measured JAK-STAT1/2 pathway activity scores in patient blood samples provided information on the adaptive immunity generated by viral infections, where a higher pathway activity was associated with development of a stronger adaptive immune response. The gene discussed is STAT1; the disease is viral infectious disease.